Interactive Investor
>>

Verona Pharma ADR (NASDAQ:VRNA) Share Price

VRNA

Verona Pharma ADR

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

Company Profile

Verona Pharma PLC is a clinical-stage biopharmaceutical company. It is known for developing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators.

NASDAQ:VRNA

US9250501064

USD

Loading...

Loading Comparison

Latest VRNA News